TotalMarketCap

Galmed Pharmaceuticals

EOCNNasdaq IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.229 M

$3.10 -3.73%

Close of 2 Nov 2026

As of 2 Nov 2026, Galmed Pharmaceuticals (EOCN) has a market capitalization of $3.23M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$10.3M

Loss-making

Shares outstanding

6,581,390

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 501 →
  1. #471OnconetixONCO$3.31M
  2. #47260 Degrees PharmaceuticalsSXTP$3.31M
  3. #473Galmed PharmaceuticalsEOCN$3.23M
  4. #474Ernexa TherapeuticsERNA$3.22M
  5. #475Kala BioKALA$3.20M

What if Galmed Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $27.3T

$26,174,823

Per share 8,443,491× higher

Bitcoin $1.54T

$1,482,915

Per share 478,360× higher

Apple $5.03T

$4,828,879

Per share 1,557,703× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Galmed Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 3 Nov 2026. Read the methodology.